Sci. STKE, 4 November 2003
IMMUNOLOGY Organ Transplantation: Extending a Brief Encounter
The need for improved specificity and lower toxicity in immune-suppressive drugs for organ transplantation has focused attention on the intracellular signaling pathways that regulate the immune responses of lymphocytes. Among these, the Janus kinase 3 (JAK3) has particular potential, because it mediates signals by several key cytokines, which each utilize a common gamma chain. Changelian et al. developed a highly selective, low-molecular-weight inhibitor of JAK3 that significantly extended organ allograft survival in primate and mouse organ transplant models after oral administration.
P. S. Changelian, M. E. Flanagan, D. J. Ball, C. R. Kent, K. S. Magnuson, W. H. Martin, B. J. Rizzuti, P. S. Sawyer, B. D. Perry, W. H. Brissette, S. P. McCurdy, E. M. Kudlacz, M. J. Conklyn, E. A. Elliott, E. R. Koslov, M. B. Fisher, T. J. Strelevitz, K. Yoon, D. A. Whipple, J. Sun, M. J. Munchhof, J. L. Doty, J. M. Casavant, T. A. Blumenkopf, M. Hines, M. F. Brown, B. M. Lillie, C. Subramanyam, C. Shang-Poa, A. J. Milici, G. E. Beckius, J. D. Moyer, C. Su, T. G. Woodworth, A. S. Gaweco, C. R. Beals, B. H. Littman, D. A. Fisher, J. F. Smith, P. Zagouras, H. A. Magna, M. J. Saltarelli, K. S. Johnson, L. F. Nelms, S. G. Des Etages, L. S. Hayes, T. T. Kawabata, D. Finco-Kent, D. L. Baker, M. Larson, M.-S. Si, R. Paniagua, J. Higgins, B. Holm, B. Reitz, Y.-J. Zhou, R. E. Morris, J. J. O'Shea, D. C. Borie, Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302, 875-878 (2003). [Abstract] [Full Text]
Citation: Organ Transplantation: Extending a Brief Encounter. Sci. STKE 2003, tw432 (2003).
The editors suggest the following Related Resources on Science sites:
In Science Magazine
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882